Krystal Biotech Inc share price logo

Krystal Biotech Inc

NASDAQ: KRYS

Mid Cap

$286.31

+20.27

(+7.62%)

as on

Krystal Biotech Inc Stock Performance

as on May 5, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $251.97
    $286.52
    downward going graph

    11.99%

    Downside

    0.07%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $122.80
    $298.30
    downward going graph

    57.11%

    Downside

    4.19%

    Upside

    downward going graph

Krystal Biotech Inc share price movements today

Previous Close
$266.04
Open
$260.00
Volume
738.8K
Day's Low - High
$251.97 - $286.52
52 Week Low - High
$122.80 - $298.30

Krystal Biotech Inc Historical Returns

1 Month Return
+ 1.95 %
3 Month Return
-0.6 %
1 Year Return
+ 63.93 %
3 Year Return
+ 215.81 %
5 Year Return
+ 270.22 %

Krystal Biotech Inc Stock Fundamentals & Key Indicators

Check Krystal Biotech Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.8B

EPS (TTM)

7.5737

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.12%

PE Ratio (TTM)

38.89

Industry PE ratio

-11.458235294117648

PEG Ratio

0

EBITDA

162.9M

Revenue (TTM)

389.1M

Profit Margin

52.64%

Return On Equity TTM

18.91%

Krystal Biotech Inc Stock Valuation

Track how Krystal Biotech Inc P/E has moved over time to understand its valuation trends.

Krystal Biotech Inc in the last 5 years

  • Overview

  • Trends

Lowest (-86.28x)

March 31, 2024

Industry (-11.46x)

May 5, 2026

Today (38.89x)

May 5, 2026

Highest (108.93x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 38.89x

Krystal Biotech Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Krystal Biotech Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$7.8B270.22%38.8952.64%
BUY$39.5B123.19%74.5912.55%
BUY$107.8B98.21%27.7132.94%
NA$32.7BNA118.975.37%
BUY$73.5B45.4%17.1229.65%

Stock Returns calculator for Krystal Biotech Inc Stock including INR - Dollar returns

The Krystal Biotech Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Krystal Biotech Inc investment value today

Current value as on today

₹1,98,964

Returns

₹98,964

(+98.96%)

Returns from Krystal Biotech Inc Stock

₹76,419 (+76.42%)

Dollar Impact

₹22,546 (+22.55%)

Analyst Recommendation on Krystal Biotech Inc Stock

Based on 17 analysts

BUY

94.12%

Buy

5.88%

Hold

0.00%

Sell

Based on 17 analysts, 94.12% of analysts recommend a 'BUY' rating for Krystal Biotech Inc. Average target price of $315

Krystal Biotech Inc Share Price Target

Get share price movements and forecasts by analysts on Krystal Biotech Inc.

What analysts predicted

9.11%UPSIDE

Target Price

$315

Current Price

$286.31

Analyzed by

17 Analysts

Target

$315.00

Krystal Biotech Inc target price $315, a slight upside of 9.11% compared to current price of $286.31. According to 17 analysts rating.

Krystal Biotech Inc Stock’s Investor Sentiment and Interest

Search interest for Krystal Biotech Inc Stock has increased by 89% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:89% versus previous 30 day period

Krystal Biotech Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
8
42
45
70
83
91
88
96
97
107
Gross Profit
8
37
42
64
77
86
83
88
92
96
Operating Income
-25
3
-6
8
22
41
36
39
41
44
EBITDA
-24
12
7
23
36
42
37
40
49
39
Interest Expense
-
25
-
-
-
-
-
-
-
-
Depreciation
0
2
1
2
1
1
1
1
1
1
Income Before Tax
80
10
0
16
29
48
43
46
47
51
Income Tax Expense
0
1
4
0
2
3
7
8
-31
0
Net Income
80
8
0
15
27
45
35
38
79
51
Net Profit Margin
943.75%
20.63%
2.06%
22.15%
32.42%
49.90%
40.52%
39.91%
81.15%
47.99%

Krystal Biotech Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
1
-
-
-
-
50
290
389
Gross Profit
0
0
0
0
-1
-2
-4
47
270
360
Operating Income
-1
-4
-11
-22
-32
-68
-145
-109
65
161
EBITDA
-1
-4
-10
-18
-30
-66
-116
-91
109
167
Interest Expense
0
3
1
-
0
1
5
-
-
-
Depreciation
-
0
0
0
1
2
4
5
6
6
Income Before Tax
-1
-7
-10
-19
-32
-69
-139
12
95
189
Income Tax Expense
-
-
0
0
1
2
34
1
6
-15
Net Income
-1
-7
-10
-19
-32
-69
-139
10
89
204
Net Profit Margin
0.00%
0.00%
-1060.27%
0.00%
0.00%
0.00%
0.00%
21.56%
30.69%
52.64%

Krystal Biotech Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
8
0
15
27
45
35
38
79
51
Operating Cash Flow
-7
15
-4
58
52
30
52
39
77
Investing Cash Flow
-10
-25
-19
-34
-83
-54
-10
-4
11
Financing Cash Flow
2
10
10
3
2
-12
1
3
15
Change in Cash
-14
0
-13
28
-29
-36
45
38
103

Krystal Biotech Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-7
-10
-19
-32
-69
-139
10
89
204
Operating Cash Flow
-3
-9
-18
-26
-47
-100
-88
123
200
Investing Cash Flow
0
-10
-4
-11
-226
-114
82
-163
-58
Financing Cash Flow
51
73
107
118
347
35
202
27
8
Change in Cash
47
54
83
80
72
-179
196
-13
151

Global Institutional Holdings in Krystal Biotech Inc

Funds
Holdings
State Street Corp
4.74%
First Trust Advisors L.P.
0.83%
venBio Select Advisor LLC
9.81%
Vanguard Group Inc
9.44%
Geode Capital Management, LLC
2.09%

Insights on Krystal Biotech Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, KRYS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, KRYS stock has moved up by 215.8%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, KRYS has outperformed top 5 stocks with highest market-cap in its industry

About Krystal Biotech Inc

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
OrganisationKrystal Biotech Inc
Headquarters2100 Wharton Street, Pittsburgh, PA, United States, 15203
IndustryBiotechnology
CEOMr. Krish S. Krishnan M.B.A., M.S.
E-voting on sharesClick here to vote

Key Management of Krystal Biotech Inc

Name

Title

Dr. David Chien M.D.

Senior Vice President of Clinical Development

Ms. Christine Wilson

Senior VP & Head of US Commercial

Mr. John Karakkal

Vice President of North American Sales & Marketing

Dr. Stephane Paquette Ph.D.

Senior Vice President of Corporate Development

Mr. Josh Suskin

Senior Director & Head of US Human Resources

Mr. Laurent Goux

Executive VP & Head of International

Mr. Krish S. Krishnan M.B.A., M.S.

Founder, Chairman, President & CEO

Ms. Suma M. Krishnan

Founder, President of R&D and Director

Ms. Kathryn A. Romano CPA

Executive VP & Chief Accounting Officer

Mr. John C. Thomas

EVP, General Counsel & Corporate Secretary

FAQs

What is Krystal Biotech Inc share price today?

Krystal Biotech Inc share price today is $286.31 as on at the close of the market. Krystal Biotech Inc share today touched a day high of $286.52 and a low of $251.97.

What is the 52 week high and 52 week low for Krystal Biotech Inc share?

Krystal Biotech Inc share touched a 52 week high of $298.3 on and a 52 week low of $122.8 on . Krystal Biotech Inc stock price today i.e. is closed at $286.31,which is 4.02% down from its 52 week high and 133.15% up from its 52 week low.

What is Krystal Biotech Inc's market capitalisation today?

Krystal Biotech Inc market capitalisation is $0.01T as on .

How to invest in Krystal Biotech Inc Stock (KRYS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Krystal Biotech Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Krystal Biotech Inc Shares that will get you 0.0052 shares as per Krystal Biotech Inc share price of $286.31 per share as on May 5, 2026 at 1:29 am IST.

What is the minimum amount required to buy Krystal Biotech Inc Stock (KRYS) from India?

Indian investors can start investing in Krystal Biotech Inc (KRYS) shares with as little as ₹95.067 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in Krystal Biotech Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Krystal Biotech Inc share’s latest price of $286.31 as on May 5, 2026 at 1:29 am IST, you will get 0.0349 shares of Krystal Biotech Inc. Learn more about fractional shares .

What are the returns that Krystal Biotech Inc has given to Indian investors in the last 5 years?

Krystal Biotech Inc stock has given 270.22% share price returns and 28.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?